327 related articles for article (PubMed ID: 17490746)
1. Fear of blindness in the Collaborative Initial Glaucoma Treatment Study: patterns and correlates over time.
Janz NK; Wren PA; Guire KE; Musch DC; Gillespie BW; Lichter PR;
Ophthalmology; 2007 Dec; 114(12):2213-20. PubMed ID: 17490746
[TBL] [Abstract][Full Text] [Related]
2. Treatment and vision-related quality of life in the early manifest glaucoma trial.
Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
[TBL] [Abstract][Full Text] [Related]
3. Depression and mood indicators in newly diagnosed glaucoma patients.
Jampel HD; Frick KD; Janz NK; Wren PA; Musch DC; Rimal R; Lichter PR;
Am J Ophthalmol; 2007 Aug; 144(2):238-244. PubMed ID: 17560843
[TBL] [Abstract][Full Text] [Related]
4. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15.
Skalicky S; Goldberg I
J Glaucoma; 2008; 17(7):546-51. PubMed ID: 18854731
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
Caprioli J; Coleman AL
Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
[TBL] [Abstract][Full Text] [Related]
6. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire.
Goldberg I; Clement CI; Chiang TH; Walt JG; Lee LJ; Graham S; Healey PR
J Glaucoma; 2009 Jan; 18(1):6-12. PubMed ID: 19142128
[TBL] [Abstract][Full Text] [Related]
7. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma.
Janz NK; Wren PA; Lichter PR; Musch DC; Gillespie BW; Guire KE; Mills RP;
Ophthalmology; 2001 Nov; 108(11):1954-65. PubMed ID: 11713062
[TBL] [Abstract][Full Text] [Related]
8. Blindness in patients with treated open-angle glaucoma.
Chen PP
Ophthalmology; 2003 Apr; 110(4):726-33. PubMed ID: 12689894
[TBL] [Abstract][Full Text] [Related]
9. Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years.
Eid TM; Spaeth GL; Bitterman A; Steinmann WC
Ophthalmology; 2003 May; 110(5):900-7. PubMed ID: 12750087
[TBL] [Abstract][Full Text] [Related]
10. Views of glaucoma patients on aspects of their treatment: an assessment of patient preference by conjoint analysis.
Bhargava JS; Patel B; Foss AJ; Avery AJ; King AJ
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2885-8. PubMed ID: 16799029
[TBL] [Abstract][Full Text] [Related]
11. A new method of assessing ability to perform activities of daily living: design, methods and baseline data.
Lorenzana L; Lankaranian D; Dugar J; Mayer J; Palejwala N; Kulkarni K; Warrian K; Boghara Z; Richman J; Wizov S; Spaeth G; Almodin J
Ophthalmic Epidemiol; 2009; 16(2):107-14. PubMed ID: 19353399
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in newly diagnosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study.
Janz NK; Wren PA; Lichter PR; Musch DC; Gillespie BW; Guire KE
Ophthalmology; 2001 May; 108(5):887-97; discussion 898. PubMed ID: 11320018
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma and quality of life: the Salisbury Eye Evaluation.
Freeman EE; Muñoz B; West SK; Jampel HD; Friedman DS
Ophthalmology; 2008 Feb; 115(2):233-8. PubMed ID: 17655930
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term progression in the early manifest glaucoma trial.
Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
[TBL] [Abstract][Full Text] [Related]
16. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
17. Natural history of open-angle glaucoma.
Heijl A; Bengtsson B; Hyman L; Leske MC;
Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma.
Law SK; Shih K; Tran DH; Coleman AL; Caprioli J
Am J Ophthalmol; 2009 Nov; 148(5):685-695.e1. PubMed ID: 19596220
[TBL] [Abstract][Full Text] [Related]
19. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh.
Nutheti R; Shamanna BR; Nirmalan PK; Keeffe JE; Krishnaiah S; Rao GN; Thomas R
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4742-8. PubMed ID: 17065482
[TBL] [Abstract][Full Text] [Related]
20. The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years.
Wong TT; Khaw PT; Aung T; Foster PJ; Htoon HM; Oen FT; Gazzard G; Husain R; Devereux JG; Minassian D; Tan SB; Chew PT; Seah SK
Ophthalmology; 2009 Feb; 116(2):175-84. PubMed ID: 19187822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
